Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123…
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and…